{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-13",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Eligible",
      "product_code": "OMN",
      "openfda": {
        "k_number": [
          "K110203",
          "K100818",
          "K110012",
          "DEN120013",
          "K113433"
        ],
        "registration_number": [
          "2022994",
          "2023365",
          "3016838963",
          "3004530258",
          "1524213"
        ],
        "fei_number": [
          "2022994",
          "2023365",
          "3016838963",
          "3004530258",
          "1524213"
        ]
      },
      "review_panel": "MI",
      "medical_specialty": "MI",
      "device_name": "C. Difficile Nucleic Acid Amplification Test Assay",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Microbiology",
      "device_class": "1",
      "definition": "In vitro diagnostic test for the qualitative detection of toxigenic clostridium difficile nucleic acids isolated and purified from stool specimens obtained from symptomatic patients.",
      "regulation_number": "866.2660",
      "implant_flag": "N",
      "submission_type_id": "4"
    }
  ]
}